Hims peptides: what they plan to sell and when

Not FDA approved

Company plans only. Not FDA approval. No prices published in the news we checked.

By the Peptide Science Desk Editorial TeamFact-checked against FDA and official sources · Oct 30, 2026Not yet reviewed by a licensed clinician. How we check facts

Short answer: Hims & Hers plans to sell peptides, but has not launched them yet. On October 29, 2026, it previewed "Peptides+" and said it plans to offer sermorelin, glutathione, B12, NAD+, and L-carnitine, with BPC-157 and TB-500 "to follow when allowable." Earlier, it told investors it aimed to sell some peptides by the end of 2026 if the rules allow. No public price list was found.

Live tracker: is the FDA peptide policy final yet?

A pharmacist in a white coat looks at a bottle of liquid medicine in front of shelves — A pharmacist checks a liquid medicine (1988 photo).Photo: Bill Branson, National Cancer Institute (NIH), public domain

Hims plans

On its mid-2026 earnings call, Hims & Hers CEO Andrew Dudum said the company plans to offer already-permitted peptides by year-end.
Fierce Healthcare reports those first products include sermorelin, glutathione, and NAD+.
Reuters (Oct 15, 2026) notes Hims has said it plans to offer peptides if regulations permit.
On October 29, 2026, Hims CEO Andrew Dudum previewed "Peptides+" on the company newsroom. Hims says it plans to offer sermorelin, glutathione, B12, NAD+, and L-carnitine first. It says treatments will be prescribed by independent providers and supplied by licensed pharmacies.

Free 2-minute quizWhich GLP-1 or peptide option fits you?Compare Wegovy, Zepbound, Ozempic and more by your goal, cost and health flags. Nothing you pick is stored. Take the GLP-1 quiz

Later products

Fierce Healthcare reports Hims is watching the FDA decision on six peptides that advisers recommended in July 2026.
Those six include BPC-157, TB-500, KPV, MOTS-c, Semax, and epitalon. Emideltide was voted down.
Dudum said Hims has started testing ingredients for those six but will wait for the FDA before selling them.
In its October 29, 2026 post, Hims said BPC-157 and TB-500 will "follow when allowable." It gave no date.

NAD+ and glutathione

People often lump them in with peptides. Chemically, NAD+ and glutathione are not the same as short peptide chains like BPC-157.
News stories still list them with Hims' early peptide plans. We keep that wording because that is how the company framed the launch.

Prices

We checked major news reports. We found no published Hims peptide price list.
If prices appear later, we will update this page from a primary source.

FDA approval?

No. Selling a compounded product is not the same as FDA approving a new drug.
On October 28, 2026, HHS issued its interim peptide policy. It covers 6 peptides, including BPC-157, made by licensed pharmacies with a prescription. It is not FDA approval. On October 29, 2026, Hims called the policy "meaningful progress" and previewed Peptides+.
Talk to a doctor. Do not treat company plans as medical advice.

Check any peptide in 1 secondFree FDA Status Checker: approved, being tested, or not proven.

FAQ

Will Hims sell BPC-157 soon?

Hims says BPC-157 and TB-500 will "follow when allowable" (October 29, 2026). It gave no date. BPC-157 is still not FDA approved.

When will Hims peptides launch?

Hims has not given a launch date for Peptides+. Company leaders said they aim for already-permitted products by the end of 2026. That is a plan, not a guarantee.

Did Hims publish prices?

Not in the news reports we checked.

Is NAD+ a peptide?

No. It is often sold next to peptides, but it is not a peptide drug like BPC-157.

Does Hims sell peptides?

Not yet, as of October 30, 2026. Hims opened a preview of Peptides+, its planned peptide line, on October 29, 2026. It says treatments will be prescribed by independent providers and made by licensed pharmacies.

Does Hims plan to sell NAD+?

Yes. Hims lists NAD+ with sermorelin, glutathione, B12, and L-carnitine as products it plans to offer in Peptides+.

We never share doses or tell you where to buy. Always ask your doctor. Print our doctor questions sheet.

Sources

Not medical advice. Medical disclaimer.